Literature DB >> 23206979

Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism.

Evrim Cakir1, Mehmet Doğan, Oya Topaloglu, Mustafa Ozbek, Erman Cakal, Mustafa Gokhan Vural, Ekrem Yeter, Tuncay Delibasi.   

Abstract

OBJECTIVE: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting reproductive-age women and is reported to be associated with an increased risk of cardiovascular disease and early atherosclerosis. Epicardial fat thickness (EF) is clinically related to subclinical atherosclerosis and visceral fat changes. Therefore, the objective of this study is to compare the carotid artery intima-media thickness (CIMT), EF and cardiometabolic risk factors in patients with PCOS, patients with idiopathic hirsutism (IH) and healthy controls.
METHODS: This cross-sectional controlled study was conducted in a training and research hospital. The study population consisted of 50 reproductive-age PCOS women, 34 women with IH and 39 control subjects. We evaluated anthropometric, hormonal and metabolic parameters as well as CIMT and EF measurements in PCOS patients, IH patients and controls.
RESULTS: The mean fasting insulin, HOMA-IR, hsCRP, GGT, CIMT, and EF levels were significantly higher in patients with PCOS and IH (p < 0.05). A significant positive correlation was found between EF and age, BMI, WHR, Ferriman Gallwey score (FG), fasting insulin, HOMA-IR, triglyceride, total cholesterol, LDL-C, 17 OH progesterone, free testosterone, CIMT, hsCRP, and GGT, whereas a significant negative correlation was observed between EF and HDL-C (p < 0.05). In the multiple linear regression analyses, EF was found to be associated with the FG (β coefficient: 0.389, p < 0.001), CIMT (β coefficient: 0.376, p < 0.001) and free testosterone levels (β coefficient: 0.173, p < 0.038).
CONCLUSION: EF appears to be a marker that will enable the detection of the cardiometabolic response in patients with PCOS and IH, even at an early stage.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23206979     DOI: 10.1016/j.atherosclerosis.2012.11.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

Review 1.  Epicardial adipose tissue in endocrine and metabolic diseases.

Authors:  Gianluca Iacobellis
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

2.  Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study.

Authors:  Samar R El Khoudary; Kelly J Shields; Imke Janssen; Carrie Hanley; Matthew J Budoff; Emma Barinas-Mitchell; Susan A Everson-Rose; Lynda H Powell; Karen A Matthews
Journal:  J Clin Endocrinol Metab       Date:  2015-07-15       Impact factor: 5.958

Review 3.  Local and systemic effects of the multifaceted epicardial adipose tissue depot.

Authors:  Gianluca Iacobellis
Journal:  Nat Rev Endocrinol       Date:  2015-04-07       Impact factor: 43.330

Review 4.  Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.

Authors:  Licy L Yanes Cardozo; Damian G Romero; Jane F Reckelhoff
Journal:  Physiology (Bethesda)       Date:  2017-09

Review 5.  Cardiovascular risk factors and events in women with androgen excess.

Authors:  D Macut; I B Antić; J Bjekić-Macut
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

Review 6.  Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.

Authors:  Krystallenia I Alexandraki; Eleni A Kandaraki; Kalliopi-Anna Poulia; Christina Piperi; Eirini Papadimitriou; Theodoros G Papaioannou
Journal:  touchREV Endocrinol       Date:  2021-04-28

7.  Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.

Authors:  Michael W O'Reilly; Angela E Taylor; Nicola J Crabtree; Beverly A Hughes; Farfia Capper; Rachel K Crowley; Paul M Stewart; Jeremy W Tomlinson; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

8.  Epicardial adipose tissue thickness and NGAL levels in women with polycystic ovary syndrome.

Authors:  Serap Baydur Sahin; Medine Cumhur Cure; Yavuz Ugurlu; Elif Ergul; Emine Uslu Gur; Nese Alyildiz; Mehmet Bostan
Journal:  J Ovarian Res       Date:  2014-02-16       Impact factor: 4.234

9.  Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome.

Authors:  Yerui Lai; Jinhua Chen; Ling Li; Jingxia Yin; Junying He; Mengliu Yang; Yanjun Jia; Dongfang Liu; Hua Liu; Yong Liao; Gangyi Yang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

10.  The relationship between epicardial fat tissue thickness and visceral adipose tissue in lean patients with polycystic ovary syndrome.

Authors:  Dilek Arpaci; Aysel Gurkan Tocoglu; Sabiye Yilmaz; Hasan Ergenc; Ali Tamer; Nurgul Keser; Huseyin Gunduz
Journal:  J Ovarian Res       Date:  2015-11-06       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.